C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling
Bone disease: Treating a complication of chronic kidney disease A naturally occurring peptide (a small protein) might be useful for treating renal osteodystrophy (ROD), a bone disease common in people with chronic kidney disease. ROD develops when kidney disease disrupts the normal metabolism of cal...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2019-07-01
|
| Series: | Experimental and Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s12276-019-0265-8 |